Ondine Biomedical Inc. (OBI.L)
GBp 9.0
(0.0%)
GBp 9.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 15.5 Million CAD | -18.59% |
| 2022 | 19.05 Million CAD | 1.47% |
| 2021 | 18.77 Million CAD | 13.64% |
| 2020 | 16.52 Million CAD | 16.63% |
| 2019 | 14.16 Million CAD | -13.74% |
| 2018 | 16.42 Million CAD | 179.39% |
| 2017 | 5.87 Million CAD | 0.0% |
| 2010 | 5.39 Million CAD | -1.92% |
| 2009 | 5.5 Million CAD | -46.42% |
| 2008 | 10.27 Million CAD | -26.82% |
| 2007 | 14.03 Million CAD | 8.72% |
| 2006 | 12.91 Million CAD | 45.5% |
| 2005 | 8.87 Million CAD | 0.0% |
| 2003 | 82.95 Thousand CAD | 19.18% |
| 2002 | 69.6 Thousand CAD | -7.13% |
| 2001 | 74.94 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 4.7 Million GBP | 0.0% |
| 2023 Q2 | 4.8 Million GBP | 0.0% |
| 2023 Q4 | 4.1 Million GBP | 0.0% |
| 2023 FY | 15.5 Million CAD | -18.59% |
| 2022 FY | 19.05 Million CAD | 1.47% |
| 2022 Q2 | 5.05 Million GBP | 0.0% |
| 2022 Q4 | 7.41 Million GBP | 0.0% |
| 2021 FY | 18.77 Million CAD | 13.64% |
| 2020 FY | 16.52 Million CAD | 16.63% |
| 2019 FY | 14.16 Million CAD | -13.74% |
| 2018 FY | 16.42 Million CAD | 179.39% |
| 2017 FY | 5.87 Million CAD | 0.0% |
| 2011 Q1 | 1.36 Million CAD | 2.49% |
| 2011 Q2 | 1.73 Million CAD | 27.49% |
| 2010 Q2 | 1.36 Million CAD | -7.5% |
| 2010 FY | 5.39 Million CAD | -1.92% |
| 2010 Q1 | 1.47 Million CAD | 6.72% |
| 2010 Q4 | 1.32 Million CAD | 7.34% |
| 2010 Q3 | 1.23 Million CAD | -8.96% |
| 2009 Q4 | 1.37 Million CAD | 14.13% |
| 2009 FY | 5.5 Million CAD | -46.42% |
| 2009 Q1 | 1.57 Million CAD | -25.76% |
| 2009 Q2 | 1.33 Million CAD | -15.2% |
| 2009 Q3 | 1.2 Million CAD | -9.87% |
| 2008 Q1 | 2.7 Million CAD | -2.72% |
| 2008 FY | 10.27 Million CAD | -26.82% |
| 2008 Q3 | 2.77 Million CAD | 4.34% |
| 2008 Q4 | 2.12 Million CAD | -23.43% |
| 2008 Q2 | 2.66 Million CAD | -1.5% |
| 2007 Q3 | 3.41 Million CAD | -14.92% |
| 2007 FY | 14.03 Million CAD | 8.72% |
| 2007 Q4 | 2.77 Million CAD | -18.73% |
| 2007 Q1 | 3.82 Million CAD | 0.16% |
| 2007 Q2 | 4.01 Million CAD | 5.2% |
| 2006 Q3 | 2.99 Million CAD | -5.05% |
| 2006 FY | 12.91 Million CAD | 45.5% |
| 2006 Q4 | 3.81 Million CAD | 27.17% |
| 2006 Q2 | 3.15 Million CAD | 7.45% |
| 2006 Q1 | 2.94 Million CAD | 20.56% |
| 2005 FY | 8.87 Million CAD | 0.0% |
| 2005 Q1 | 1.87 Million CAD | 173.29% |
| 2005 Q2 | 2.35 Million CAD | 25.41% |
| 2005 Q3 | 2.21 Million CAD | -5.93% |
| 2005 Q4 | 2.43 Million CAD | 10.29% |
| 2004 Q3 | 1.56 Million CAD | 22.53% |
| 2004 Q4 | 685.86 Thousand CAD | -56.12% |
| 2004 Q2 | 1.27 Million CAD | -28.45% |
| 2004 Q1 | 1.78 Million CAD | 3587.3% |
| 2003 FY | 82.95 Thousand CAD | 19.18% |
| 2003 Q1 | 20.16 Thousand CAD | 1160.19% |
| 2003 Q4 | 48.34 Thousand CAD | 41.02% |
| 2003 Q3 | 34.28 Thousand CAD | 27.41% |
| 2003 Q2 | 26.9 Thousand CAD | 33.44% |
| 2002 Q1 | 14.16 Thousand CAD | -41.17% |
| 2002 Q3 | 8174.00 CAD | -64.74% |
| 2002 Q4 | 1600.00 CAD | -80.43% |
| 2002 FY | 69.6 Thousand CAD | -7.13% |
| 2002 Q2 | 23.18 Thousand CAD | 63.65% |
| 2001 Q4 | 24.07 Thousand CAD | 0.0% |
| 2001 FY | 74.94 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|